Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × carotuximab × Clear all

NCT01375569 2017-07-28

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Phase 2 Completed

11 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms